Novo Nordisk (NVO)
(Real Time Quote from BATS)
$127.37 USD
+1.58 (1.26%)
Updated Apr 26, 2024 02:36 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Income Statements
Fiscal Year end for Novo Nordisk AS falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 33,724 | 25,057 | 22,401 | 19,448 | 18,291 |
Cost Of Goods | 5,193 | 4,028 | 3,764 | 3,207 | 3,011 |
Gross Profit | 28,531 | 21,028 | 18,637 | 16,241 | 15,280 |
Selling & Adminstrative & Depr. & Amort Expenses | 13,637 | 10,436 | 9,307 | 7,949 | 7,413 |
Income After Depreciation & Amortization | 14,894 | 10,593 | 9,330 | 8,292 | 7,867 |
Non-Operating Income | 428 | 34 | 459 | 249 | 10 |
Interest Expense | 123 | 848 | 390 | 402 | 599 |
Pretax Income | 15,199 | 9,779 | 9,400 | 8,140 | 7,278 |
Income Taxes | 3,048 | 1,917 | 1,801 | 1,684 | 1,439 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 12,151 | 7,862 | 7,598 | 6,456 | 5,839 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 12,151 | 7,862 | 7,598 | 6,456 | 5,839 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 16,261 | 11,635 | 10,289 | 9,173 | 8,716 |
Depreciation & Amortization (Cash Flow) | 1,367 | 1,042 | 959 | 881 | 849 |
Income After Depreciation & Amortization | 14,894 | 10,593 | 9,330 | 8,292 | 7,867 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 4,494.25 | 4,543.78 | 4,594.23 | 4,669.03 | 4,755.92 |
Diluted EPS Before Non-Recurring Items | 2.70 | 1.73 | 1.65 | 1.38 | 1.23 |
Diluted Net EPS (GAAP) | 2.70 | 1.73 | 1.65 | 1.38 | 1.23 |
Fiscal Year end for Novo Nordisk AS falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 9,526.16 | 8,574.73 | 7,933.23 | 7,690.19 |
Cost Of Goods | NA | 1,448.19 | 1,418.10 | 1,147.76 | 1,179.03 |
Gross Profit | NA | 8,077.96 | 7,156.63 | 6,785.47 | 6,511.16 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4,207.07 | 3,227.33 | 3,295.44 | 2,907.65 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3,870.89 | 3,929.30 | 3,490.03 | 3,603.51 |
Non-Operating Income | NA | -138.53 | 484.43 | -41.05 | 122.77 |
Interest Expense | NA | -260.99 | 316.53 | -94.53 | 161.68 |
Pretax Income | NA | 3,993.36 | 4,097.20 | 3,543.51 | 3,564.60 |
Income Taxes | NA | 818.00 | 815.41 | 705.08 | 709.40 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 3,175.36 | 3,281.79 | 2,838.43 | 2,855.20 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 3,175.36 | 3,281.79 | 2,838.43 | 2,855.20 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 4,477.40 | 4,489.00 | 4,502.43 | 4,513.44 |
Diluted EPS Before Non-Recurring Items | NA | 0.71 | 0.73 | 0.63 | 0.64 |
Diluted Net EPS (GAAP) | NA | 0.71 | 0.73 | 0.63 | 0.63 |